Home
Categories
EXPLORE
True Crime
Comedy
Society & Culture
Business
News
Sports
TV & Film
About Us
Contact Us
Copyright
© 2024 PodJoint
Podjoint Logo
US
00:00 / 00:00
Sign in

or

Don't have an account?
Sign up
Forgot password
https://is1-ssl.mzstatic.com/image/thumb/PodcastSource221/v4/c8/d6/70/c8d670b5-7c4d-d04b-67d1-947a63eea8a6/3ee9bb88-a6e7-413e-a2e0-69244930a421.jpg/600x600bb.jpg
Method Made: The Tech Transfer Edge in Cell & Gene Therapy
Nico
12 episodes
6 days ago
In the competitive cell and gene therapy landscape, speed and efficiency are paramount. The biggest roadblock? The operational friction in tech transfer. This podcast is for executives focused on building a durable competitive advantage. We explore how to transform tech transfer from your biggest risk into your greatest asset. By solving the deep operational challenges and aligning perfectly with your CDMO partner, you can shorten timelines, protect capital, and get your therapy to patients faster. Move beyond day-to-day problems and learn to build a tech transfer strategy that wins.
Show more...
Life Sciences
Science
RSS
All content for Method Made: The Tech Transfer Edge in Cell & Gene Therapy is the property of Nico and is served directly from their servers with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
In the competitive cell and gene therapy landscape, speed and efficiency are paramount. The biggest roadblock? The operational friction in tech transfer. This podcast is for executives focused on building a durable competitive advantage. We explore how to transform tech transfer from your biggest risk into your greatest asset. By solving the deep operational challenges and aligning perfectly with your CDMO partner, you can shorten timelines, protect capital, and get your therapy to patients faster. Move beyond day-to-day problems and learn to build a tech transfer strategy that wins.
Show more...
Life Sciences
Science
https://d3t3ozftmdmh3i.cloudfront.net/staging/podcast_uploaded_nologo/43586344/43586344-1746180923089-d836c463cdac2.jpg
CDMO Veteran Nithya Jesuraj Reveals the Documentation Gap Killing Biotech Tech Transfers
Method Made: The Tech Transfer Edge in Cell & Gene Therapy
45 minutes 21 seconds
5 months ago
CDMO Veteran Nithya Jesuraj Reveals the Documentation Gap Killing Biotech Tech Transfers

Nithya shares what she's learned from years in CDMO business development and technical operations. From the post-pandemic CDMO boom to today's "minimum viable process" reality, she breaks down why small biotechs struggle with tech transfer documentation.

Key insights:

  • Why PowerPoint presentations aren't tech transfer documentation (and CDMOs are saying no)
  • The mindset shift from academic protocols to manufacturing SOPs
  • How engineering runs become make-or-break decisions for cash-strapped biotechs
  • Why treating R&D as a scale-down model of manufacturing changes everything
  • The hidden costs of not thinking like a product manager from day one

Nithya explains the communication breakdowns between brilliant scientists and manufacturing experts - and what it takes to bridge that gap successfully.

Perfect for biotech founders, process development teams, and anyone navigating the transition from discovery to manufacturing.

Method Made: The Tech Transfer Edge in Cell & Gene Therapy
In the competitive cell and gene therapy landscape, speed and efficiency are paramount. The biggest roadblock? The operational friction in tech transfer. This podcast is for executives focused on building a durable competitive advantage. We explore how to transform tech transfer from your biggest risk into your greatest asset. By solving the deep operational challenges and aligning perfectly with your CDMO partner, you can shorten timelines, protect capital, and get your therapy to patients faster. Move beyond day-to-day problems and learn to build a tech transfer strategy that wins.